Hospitals Continue Lobbying Push to Extend Pandemic-Era 340B Eligibility Waiver

Heywood Hospital joined a coalition of 340B hospitals and providers groups that has asked Congress to extend a 340B eligibility exemption waiver.
A growing coalition of 340B hospitals has asked lawmakers to extend 340B program eligibility exemptions first authorized during the COVID-19 [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Senate Committee Doubles Down on PBM Bill with 340B Spread Pricing Language

Sen. Ron Wyden (D-Ore.), chairman of the Senate Finance Committee, announced a Dec. 5 hearing on prescription drug shortages that will include testimony from two witnesses who have published research on the 340B program.
Members of the Senate Finance Committee yesterday reiterated support for a pharmacy benefit manager (PBM) transparency bill with 340B spread [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Indiana Health Care Leaders Call for 340B Transparency in Op-Ed

Two Indiana Health Center leaders—TJ Warren (left) and Ben Harvey (right)—called for greater 340B program transparency in a recent op-ed.
The CEOs of an Indiana-based community health center and a primary care association recently wrote an op-ed that called for [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Lobbying Still on Track for Record Year

Darbin Wofford, a health policy advisor at Third Way, said his organization is urging Congressional Democrats to adopt 340B program reforms.
Lobbying on 340B issues in 2023 remains on track for a record-breaking year, according to recently released congressional lobbying reports. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Provider-Genentech Lobbying Group Boosts Spending, Adds Members

340B Working Table
More than 360 firms reported lobbying on the 340B program between July 1 and Sept. 30.
Genentech, Sanford Health, and Carolina Health Centers’ 340B reform group, 340B Working Table, spent $110,000 on lobbying and gained eight [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

New House Speaker’s 340B Stance Unclear But Supported 340B Hospitals in 2017 Bill

Mike Johnson
New U.S. House Speaker Mike Johnson (R-La.) has received campaign donations from multiple 340B program stakeholders.
Rep. Mike Johnson (R-La.), the new speaker of the U.S. House, has received campaign donations from multiple 340B stakeholders but [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Louisiana AG Election to Name Enforcer, Defender of 340B Contract Pharmacy Law

Democrat Lindsey Cheek (left) and Republican Elizabeth Murrill (right) are running to be the next Louisiana attorney general.
A November election for Louisiana attorney general will determine the primary official who both enforces its 340B contract pharmacy law [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Column: Look to The Senate for 340B Action

Ted Slafsky, publisher and CEO of 340B Report, writes the second part of his two-part column on the Senate "group of six" 340B discussion draft.
According to our history lessons, George Washington told Thomas Jefferson that the Senate was created to serve as a saucer [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

CMS Seeks Input on Contractor to Prevent 340B, Medicare Maximum Price Duplication

Kelsey Lang Avalere
Kelsey Lang, a health policy principal at Avalere, said CMS's request for information affirms its interest in preventing 340B duplicate discounts.
Regulators are seeking input on a contractor to help it shield drug manufacturers from giving duplicate 340B discounts and new [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Congressional Witnesses Urge Medicare 340B Cuts

Dr. Debra Patt, executive vice president at Texas Oncology, testified during a House subcommittee hearing that the 340B program was "broken."
Witnesses recently told a U.S. House subcommittee that Congress should cut Medicare payments for 340B drugs. The House Energy and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live